*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
You are seeing these quotes based on previous browsing related to sectors such as
BTG (BTGL)
0.00p
13:55 20/12/24
0.00%0.00p
Today's Low & High
0.00 / 0.00
Open / Previous Close
0.00 / 0.00
52-week range
0.00%0.00p
Volume
0
Market Cap(million)
£0.00m
Advertising
BTG - Overview
BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.
Registrars:
Key Personnel
CFO:
Duncan Kennedy
Non-Executive Director:
Richard Wohanka , Gregory Barrett , Susan (Sue) Foden, Anne Thorburn, William James (Jim) O'Shea, Ian F R Much